Top Wall Street Forecasters Revamp Walgreens Expectations Ahead Of Q3 Earnings

1. WBA's Q3 earnings expected to drop to 34 cents per share. 2. Revenue projection slightly increased to $36.72 billion year-over-year. 3. Walgreens to pay $300 million to settle opioid prescription allegations. 4. Deutsche Bank downgraded WBA from Hold to Sell with a $9 price target. 5. Analysts are mixed; some maintain neutral or hold ratings.